(Q45121099)

9 December 2017

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection (English)

1 reference

9 December 2017

1 reference

1 reference

1 reference

Suzuki Y

1

1 reference

9 December 2017

Kumada H

2

1 reference

9 December 2017

Ikeda K

3

1 reference

9 December 2017

Chayama K

4

1 reference

9 December 2017

Arase Y

5

1 reference

9 December 2017

Saitoh S

6

1 reference

9 December 2017

Tsubota A

7

1 reference

9 December 2017

Kobayashi M

8

1 reference

9 December 2017

Koike M

9

1 reference

9 December 2017

Ogawa N

10

1 reference

9 December 2017

Tanikawa K

11

1 reference

9 December 2017

1 May 1999

1 reference

9 December 2017

Journal of Hepatology

1 reference

9 December 2017

30

1 reference

9 December 2017

5

1 reference

9 December 2017

743-748

1 reference

(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro

9 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980123-8

7 January 2021

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980123-8

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980123-8

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980123-8

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980123-8

7 January 2021

10.1016/S0168-8278(99)80123-8

Identifiers

DOI

1 reference

9 December 2017

1 reference